Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0279628|esophageal adenocarcinoma |
Sentences | 2 |
PubMedID- 22759597 | Tumor response to an s-1 regimen in patients with advanced esophageal adenocarcinoma, however, remains to be elucidated. |
PubMedID- 21258083 | Conclusion: 5-fluorodeoxyuridine, leucovorin, oxaliplatin and docetaxel regimen is active in patients with esophageal adenocarcinoma. |
Page: 1